Comparison of the Two and Six- Minute Walk Tests in Evaluating Oxygen Desaturation in Patients With Severe COPD
Study Details
Study Description
Brief Summary
All measurements are performed on two consecutive days at the beginning of a pulmonary rehabilitation program in a randomized cross-over study design. On the first day, each patient is randomly assigned to perform either the 2 minute walk test or the 6 Minute walk test. On the second day each patient performs the test that was not performed on the first day. All walk tests are performed by the same investigator on the same track and time of day, following the 2002 guidelines of the American Thoracic Society.
Patients wear a mobile pulse oximeter that continuously records heart rate and oxygen saturation during testing. Baseline values of oxygen saturation, heart rate and ratings of perceived exertion on the modified Borg scale (0 to 10) for dyspnea and leg fatigue are recorded at rest after 10 minutes of sitting.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: 2 minute walk test
|
Other: walk tests
|
Other: 6 minute walk test
|
Other: walk tests
|
Outcome Measures
Primary Outcome Measures
- oxygen desaturation [up to 6 minute walk test]
Secondary Outcome Measures
- heart rate [during 2 minute walk test and 6 minute walk test]
- perceived exertion for dyspnea and leg fatigue [during 2 minute walk test and 6 minute walk test]
measured by a modified Borg scale from 0 to 10
Eligibility Criteria
Criteria
Inclusion Criteria:
-
confirmed diagnosis of chronic obstructive lung disease stage III or IV according to the Global Initiative for chronic Obstructive Lung Diseases definition
-
ability to read and understand the German language and study procedures.
-
written informed consent
Exclusion Criteria:
-
severe acute exacerbation of chronic obstructive lung disease
-
severe respiratory failure (partial Oxygen pressure at rest lower than 55 millimeter mercury)
-
non compliance to the study protocol.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Schön Klinik Berchtesgadener Land
Investigators
- Principal Investigator: Klaus Kenn, MD, Schoen Klinik Berchtesgadener Land
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- walk test trial